LXR ligands induce apoptosis of EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt-NF-κB activation

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are efficient in treating patients with non-small cell lung cancer (NSCLC) harboring EGFR activating mutations. Unfortunately, nearly all patients ultimately acquire resistance to EGFR-TKI treatment. Liver X receptors (LXRs) can...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Liu, Siwen, Cao, Haixia, Chen, Dan, Yu, Shaorong, Sha, Huanhuan, Wu, Jianzhong, Ma, Rong, Wang, Zhuo, Jing, Changwen, Zhang, Junying, Feng, Jifeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2018
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921072/
https://ncbi.nlm.nih.gov/pubmed/29731879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8182
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller